Actemra 200mg/10 ml infusion vial

Actemra 200mg/10 ml concentrate for infusion

Actemra 200mg/10 ml by Roche contains tocilizumab, a monoclonal antibody that targets interleukin-6 (IL-6) receptors. It is a biological medicine, not an antibiotic.

What is Actemra used for?

Actemra is used for rheumatoid arthritis under specialist supervision. The appropriate treatment depends on the diagnosis, previous treatment and the approved indications for the specific presentation.

Product details

• Brand: Actemra.
• Manufacturer: Roche.
• Active ingredient: tocilizumab.
• Strength: 200 mg in 10 ml.
• Dosage form: concentrate for solution for intravenous infusion.
• Presentation: one vial.

How does tocilizumab work?

Tocilizumab blocks IL-6 receptors, helping reduce inflammatory signalling involved in rheumatoid arthritis.

Frequently asked questions

Is Actemra an antibiotic?
No. Tocilizumab is a monoclonal antibody and biological medicine.

Is this presentation for intravenous infusion?
Yes. This listing is for the 200mg/10 ml concentrate for intravenous infusion, not a pre-filled injection pen.

Are different Actemra strengths interchangeable?
The vial strength and total prescribed dose must match the specialist's treatment plan. A different strength is not a direct one-for-one replacement.

Active ingredient: tocilizumab, 200 mg in 10 ml.